17 April 2021
Digital Event

Sponsorship & Exhibition

Industry Symposia

Saturday, 17 April 2021

12:00 – 13:15 (CET)

Industry Symposium Sanofi Genzyme / Regeneron
Impacto de la inflamación de Tipo 2 en la vía aérea. Una visión multidisciplinar / Impact of Type 2 inflammation on the airways. A multidisciplinary vision

* Please note: This Industry Session will be offered in Spanish

Bienvenida / Welcome, Antonio Valero

Visión del alergólogo de la vía aérea única: El asma y sus comorbilidades / Respiratory airway from Allergist's perspective: asthma and its comorbidities, Jose Maria Vega Chicote

Visión del otorrino de la vía aérea única: La RSCcPN y sus comorbilidades / ENT's view of the respiratory airway: CRSRN and its comorbidities, Alfonso del Cuvillo

Debate y preguntas / Questions and Discussion, Antonio Valero, Jose Maria Vega Chicote, Alfonso del Cuvillo

13:30 – 14:45 (CET)

Industry Symposium Sanofi Genzyme / RegeneronSAGZ Regeneron Logo 600px
Dupilumab for the Treatment of Type 2 Airway Diseases: Expert Panel Discussion of Clinical Evidence and Experience

Opening Remarks & Panel Introductions, G. Walter Canonica, Mona Al-Ahmad, Ludger Klimek

Type 2 Inflammation in Diseases of the Upper and Lower Airway, Mona Al-Ahmad

Review of the Evidence for Dupilumab: Asthma, G. Walter Canonica

Review of the Evidence for Dupilumab: CRSwNP, Ludger Klimek

Panel Discussion and Audience Q&A, G. Walter Canonica, Mona Al-Ahmad, Ludger Klimek

Clinical Experience With Dupilumab for the Treatment of Severe Type 2 Asthma and CRSwNP, Mona Al-Ahmad, Ludger Klimek

Audience Q&A and Closing Remarks, G. Walter Canonica, Mona Al-Ahmad, Ludger Klimek
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback